Teva Pharmaceutical Industries Limited (VIE:TEVA)

Market Cap	27.95B
Revenue (ttm)	14.30B
Net Income (ttm)	607.69M
Shares Out	n/a
EPS (ttm)	0.53
PE Ratio	45.99
Forward PE	10.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	114
Open	23.90
Previous Close	23.60
Day's Range	23.80 - 24.20
52-Week Range	11.30 - 24.40
Beta	n/a
RSI	78.24
Earnings Date	Jan 28, 2026

About VIE:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

In 2024, VIE:TEVA's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD